Correlation Between Compugen and Enlivex Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Compugen and Enlivex Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Compugen and Enlivex Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Compugen and Enlivex Therapeutics, you can compare the effects of market volatilities on Compugen and Enlivex Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Compugen with a short position of Enlivex Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Compugen and Enlivex Therapeutics.

Diversification Opportunities for Compugen and Enlivex Therapeutics

0.38
  Correlation Coefficient

Weak diversification

The 3 months correlation between Compugen and Enlivex is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding Compugen and Enlivex Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enlivex Therapeutics and Compugen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Compugen are associated (or correlated) with Enlivex Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enlivex Therapeutics has no effect on the direction of Compugen i.e., Compugen and Enlivex Therapeutics go up and down completely randomly.

Pair Corralation between Compugen and Enlivex Therapeutics

Assuming the 90 days trading horizon Compugen is expected to generate 1.53 times more return on investment than Enlivex Therapeutics. However, Compugen is 1.53 times more volatile than Enlivex Therapeutics. It trades about 0.05 of its potential returns per unit of risk. Enlivex Therapeutics is currently generating about -0.02 per unit of risk. If you would invest  33,080  in Compugen on September 3, 2024 and sell it today you would earn a total of  25,020  from holding Compugen or generate 75.63% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Compugen  vs.  Enlivex Therapeutics

 Performance 
       Timeline  
Compugen 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Compugen has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Enlivex Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Enlivex Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Compugen and Enlivex Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Compugen and Enlivex Therapeutics

The main advantage of trading using opposite Compugen and Enlivex Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Compugen position performs unexpectedly, Enlivex Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enlivex Therapeutics will offset losses from the drop in Enlivex Therapeutics' long position.
The idea behind Compugen and Enlivex Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Complementary Tools

USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Fundamental Analysis
View fundamental data based on most recent published financial statements